Clinical trial
Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches
NCT00172094 · Shire, Industry · Completed
Key facts
| NCT number | NCT00172094 |
|---|---|
| Title | Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches |
| Official title | A Phase 2 Safety and Efficacy Study of NPS 1776 for the Acute Treatment of Migraine Headaches |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Migraine Headache |
| Intervention type | Drug |
| Interventions | NPS 1776 (800 mg), PLACEBO, NPS 1776 (400 mg) |
| Enrollment | 189 |
| Start date | Dec 31, 2003 |
| Primary completion | Jun 30, 2004 |
| Completion | Jul 31, 2004 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 3, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: